0001209191-13-028457.txt : 20130523
0001209191-13-028457.hdr.sgml : 20130523
20130523161433
ACCESSION NUMBER: 0001209191-13-028457
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130522
FILED AS OF DATE: 20130523
DATE AS OF CHANGE: 20130523
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SACHS BRUCE I
CENTRAL INDEX KEY: 0001197036
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 13868484
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
BUSINESS PHONE: 6173416100
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2013-05-22
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197036
SACHS BRUCE I
C/O VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY ST.
CAMBRIDGE
MA
02139
1
0
0
0
Common Stock
2013-05-22
4
S
0
2500
78.48
D
110410
D
Common Stock
2013-05-22
4
S
0
1538
79.50
D
108872
D
Common Stock
2013-05-22
4
S
0
4262
80.63
D
104610
D
Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $78.48 (range $77.94 to $78.82).
Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $79.50 (range $79.00 to $79.98).
Open market sales reported on this line occurred at a weighted average price of $80.63 (range $80.01 to $81.00).
Kenneth L. Horton, Attorney-In-Fact
2013-05-23